Skip to main content
    O

    Organogenesis Holdings Inc (ORGO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.81
    +0.01 (+1.06%)

    Market Cap: $104.24M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Organogenesis Holdings Inc (ORGO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Organogenesis Holdings (ORGO) has a latest price of $0.81 on Nov 17, 2026, 86.3% below its 52-week high of $5.91. Its price fell 86.7% over the past 12 months. The month-end price fell 92.2% since Jan 2017, a compound annual decline of 23.0%.

    Price Chart

    From Jan 2017 to Oct 2026, its highest month-end close was $22.36 in Apr 2021 and its lowest $0.77 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ORGO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ORGO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 57.5%, and over 6 months it fell 66.6%. The month-end price fell 65.7% over the 3 years through Oct 2026, a compound annual decline of 30.0%.

    PeriodChange
    1 month-20.4%
    3 months-57.5%
    6 months-66.6%
    12 months-86.7%
    12 months, with dividends-86.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-65.7%-30.0%
    5 years-93.0%-41.3%
    Since Jan 2017-92.2%-23.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 61.9%, and its weakest was 2022, when it fell 70.9%.

    YearCloseChange
    2026 through Oct 2026$0.77-85.2%
    2025$5.18+61.9%
    2024$3.20-21.8%
    2023$4.09+52.0%
    2022$2.69-70.9%
    2021$9.24+22.7%
    2020$7.53+56.5%
    2019$4.81-52.6%
    2018$10.15+2.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 29.6% below its 50-day average of $1.15 and 62.9% below its 200-day average of $2.19.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.81
    52-week high$5.91-86.3%
    52-week low$0.73+11.2%
    50-day average$1.15-29.6%
    200-day average$2.19-62.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.5%.

    MeasureValue
    1-year beta1.23
    Largest fall, 1 year-87.4%
    Largest fall, 3 years-88.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Organogenesis Holdings traded at 17.9x earnings at the end of 2025, against a 5-year median of 21.3x.

    ORGO valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ORGO

    What is ORGO's 1-year price change?

    Organogenesis Holdings's price fell 86.7% over the past 12 months. With dividends included, the 12-month total return was -86.7%.

    What is ORGO's 5-year price change?

    Organogenesis Holdings's month-end price fell 93.0% over the 5 years through Oct 2026, a compound annual decline of 41.3%. These figures leave out dividends.

    What is ORGO's 52-week high and low?

    Organogenesis Holdings's 52-week high is $5.91 and its 52-week low is $0.73. Its latest price of $0.81 on Nov 17, 2026 is 86.3% below the high.

    What is ORGO's beta?

    Organogenesis Holdings's 1-year beta against the S&P 500 is 1.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.4%.

    Is the ORGO chart free?

    Yes. Advanced Charting for ORGO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.